180 related articles for article (PubMed ID: 34253112)
21. Factors associated with unknown primary status in head and neck squamous cell carcinoma.
Kalavacherla S; Li V; Voora R; Victor M; Faraji F; Guo T
Oral Oncol; 2024 Jan; 148():106650. PubMed ID: 38039876
[TBL] [Abstract][Full Text] [Related]
22. Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
Stepan K; Craig E; Skillington SA; Deutsch BC; Chen S; Wamkpah NS; Bollig CA; Kallogjeri D; Thorstad WL; Puram SV; Pipkorn P; Jackson RS
Head Neck; 2022 May; 44(5):1069-1078. PubMed ID: 35175648
[TBL] [Abstract][Full Text] [Related]
23. Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma.
Yan EZ; Wahle BM; Massa ST; Zolkind P; Paniello RC; Pipkorn P; Jackson RS; Rich JT; Puram SV; Mazul AL
Cancer Med; 2023 Apr; 12(8):9976-9987. PubMed ID: 36847063
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of human papillomavirus detection and the eighth edition of the TNM classification staging system in oropharyngeal squamous cell carcinoma: A single-center Polish study.
Durzynska M; Kiprian D; Szumera-Cieckiewicz A; Leszczynski P; Florek A; Snietura M; Michalek IM; Bakula-Zalewska E; Prochorec-Sobieszek M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Jun; 133(6):698-705. PubMed ID: 35165063
[TBL] [Abstract][Full Text] [Related]
25. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
26. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
Sher DJ; Rusthoven CG; Khan SA; Fidler MJ; Zhu H; Koshy M
Cancer; 2017 Jan; 123(2):273-282. PubMed ID: 27649421
[TBL] [Abstract][Full Text] [Related]
27. Influence of human papillomavirus on the clinical presentation of oropharyngeal carcinoma in the United States.
Stenmark MH; Shumway D; Guo C; Vainshtein J; Mierzwa M; Jagsi R; Griggs JJ; Banerjee M
Laryngoscope; 2017 Oct; 127(10):2270-2278. PubMed ID: 28304083
[TBL] [Abstract][Full Text] [Related]
28. Neck scar perception after neck dissection in HPV-associated oropharyngeal squamous cell carcinoma.
Au VH; Miller LE; Mitchell MB; Larson AR; Lin DT; Feng AL; Richmon JD
Am J Otolaryngol; 2024; 45(1):104074. PubMed ID: 37865986
[TBL] [Abstract][Full Text] [Related]
29. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.
Khalid MB; Ting P; Pai A; Russo JL; Bakst R; Chai RL; Teng MS; Genden EM; Miles BA
Laryngoscope; 2019 Apr; 129(4):877-882. PubMed ID: 30194702
[TBL] [Abstract][Full Text] [Related]
30. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
31. Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status.
Stein E; Lenze NR; Yarbrough WG; Hayes DN; Mazul A; Sheth S
Head Neck; 2020 Oct; 42(10):2985-3001. PubMed ID: 32632953
[TBL] [Abstract][Full Text] [Related]
32. Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
Lee DS; Mahal RS; Tharakan T; Cathryn Collopy ; Kallogjeri D; Thorstad WL; Adkins DR; Oppelt P; Ley J; Wick CC; Zevallos J
Otolaryngol Head Neck Surg; 2023 May; 168(5):1089-1096. PubMed ID: 36939390
[TBL] [Abstract][Full Text] [Related]
33. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
[TBL] [Abstract][Full Text] [Related]
34. Human Papillomavirus-Negative Oropharyngeal Cancer Survival Outcomes Based on Primary Treatment: National Cancer Database Analysis.
Shama M; Al-Qurayshi Z; Dahl M; Amdur RJ; Bates J; Mendenhall W; Hitchcock K; Festa BM; Ghanem T; Dziegielewski PT
Otolaryngol Head Neck Surg; 2022 Jul; 167(1):100-108. PubMed ID: 34546828
[TBL] [Abstract][Full Text] [Related]
35. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review protocol.
Lee TJ; Krishnan G; Ooi EH; Barker TH
JBI Evid Synth; 2022 Apr; 20(4):1135-1141. PubMed ID: 34698708
[TBL] [Abstract][Full Text] [Related]
37. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review.
Dowthwaite S; Jackson J; Dzienis M; Khoo E; Cronin M; Guazzo E
Curr Oncol Rep; 2023 May; 25(5):501-510. PubMed ID: 36881215
[TBL] [Abstract][Full Text] [Related]
38. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
[TBL] [Abstract][Full Text] [Related]
39. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
[TBL] [Abstract][Full Text] [Related]
40. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
